Term of Royalty Obligation. Royalties on the Licensed Product shall commence upon the First Commercial Sale of a Licensed Product in a particular country in the Territory and will continue on a product-by-product, country-by-country basis until the later of (i) the expiration of the last to expire Valid Claim of the Compound Patent Rights covering a Licensed Product in such country or (ii) the tenth (10th) anniversary of the date of the First Commercial Sale of the Licensed Product in such country.
Term of Royalty Obligation. Royalty payments shall be paid on the Products commencing on the Effective Date, and unless earlier terminated as provided herein, shall continue on a country-by-country and Product-by-Product basis until there are no remaining royalty payment obligations in a country, at which time the Agreement shall expire in its entirety in such country. Royalty payments shall cease for any patent which has been declared invalid or unenforceable by a final determination or judgment, or if this Agreement is terminated as hereinafter specified and provided.
Term of Royalty Obligation. 10 Sublicenses..........................................................................................
Term of Royalty Obligation. The “Full Royalty Term” for a particular Licensed Product in a particular country shall commence with the First Commercial Sale of such Licensed Product in such country and shall terminate upon the later of (a) the expiration of the last-to-expire of (i) issued Targacept Patent Rights, (ii) issued APSA Patent Rights covering the composition of the Development Compound constituting or included in the Licensed Product, (iii) issued APSA Patent Rights covering inventions during the Research Term or (iv) Joint Patent Rights covering inventions during the Research Term, for which at least one Valid Claim exists covering the sale of such Licensed Product or its use in the Field, in such country, or (b) the [********] anniversary of the First Commercial Sale of such Licensed Product in such country. The “Partial Royalty Term” (if any) for a particular Licensed Product in a particular country shall commence immediately after the Full Royalty Term of such Licensed Product in such country and shall terminate upon the [********] anniversary of the First Commercial Sale of such Licensed Product in such country.
Term of Royalty Obligation. Subject to the termination provisions of Article 14 of this Agreement, Abxxxx'x xbligation to pay royalties on Products in each country shall expire on the date when the last patent containing a Valid Claim in such country expires, lapses or is invalidated.
Term of Royalty Obligation. The obligation to pay Royalty(ies) under this Section 7.1(A) shall expire on a Compound-by-Compound and country-by-country basis [* * *].
Term of Royalty Obligation. Scios' obligation to pay royalties on Therapeutic Products under Section 5.2 will expire, on a country-by-country basis, on the date when the last Valid Claim within the Shionogi Patent Rights in the country of sale expires, lapses or is invalidated.
Term of Royalty Obligation. Royalties on the Licensed Product shall commence upon the First Commercial Sale of a Licensed Product in a particular country in the Territory and will continue on a product-by-product, country-by-country basis until the later of (i) the expiration of the last to expire Valid Claim covering a Licensed Product in such country or (ii) the [ * ] anniversary of the date of the First Commercial Sale of the Licensed Product in such country (“Royalty Term”). For clarity, during the Royal Term, the royalty payments pursuant to this Section 7.3 shall be payable regardless of whether Licensee, its Affiliate, or its sublicensee is selling the Licensed Product.
Term of Royalty Obligation. Wyeth-Ayerst shall be obligated to pay royalties on each Royalty-Bearing Product on a country-by-country basis for the Royalty Period. Thereafter, Wyeth-Ayerst shall have a fully paid up license from ArQule with respect to such Royalty-Bearing Product.
Term of Royalty Obligation. The “Royalty Term” for a particular Alliance Product in a particular country shall commence with the First Commercial Sale of such Alliance Product in such country and shall terminate upon the later of (a) the expiration of the last-to-expire issued Aventis Patent in such country, if any, for which at least one Valid Claim exists covering the sale of such Alliance Product or its use in the Field or (b) the [********] anniversary of the First Commercial Sale of such Alliance Product in such country.
